Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: Inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells

被引:46
|
作者
Buseyne, F
Fevrier, M
Garcia, S
Gougeon, ML
Riviere, Y
机构
[1] INST PASTEUR,UNITE VIROL & IMMUNOL CELL,F-75724 PARIS 15,FRANCE
[2] INST PASTEUR,URA CNRS 1157,UNITE ONCOL VIRALE,F-75724 PARIS 15,FRANCE
关键词
D O I
10.1006/viro.1996.0597
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CD8+ T cells may play a beneficial role in human immunodeficiency virus (HIV)-infected patients by two mechanisms: HIV-specific cytotoxic activity and secretion of a soluble mediator(s) that inhibits HIV replication in vitro. Here we characterized both activities mediated by an HIV p24(gag)-specific cytotoxic T lymphocyte (CTL) CD8+ clone derived from an HIV-infected patient. When the CTL clone was mixed with HIV-infected autologous CD4+ T cells, viral replication was suppressed. This viral inhibition was observed in heterologous CD4+ T cells and when CD8+ and CD4+ populations were separated by a semipermeable membrane, demonstrating the involvement of a diffusible factor(s), The lysis of autologous HIV-infected T cells was also detected. However, HIV suppression was more efficient when CD4+ and CD8+ T cells shared major histocompatibility complex alleles and were in direct contact. Thus, one and the same CD8+ T cell population can mediate both lysis of HIV-infected targets and nonlytic suppression of HIV replication. These results underline the multiple roles of CD8+ T lymphocytes in the suppression of HIV-infected cells. (C) 1996 Academic Press, Inc.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 50 条
  • [1] Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians
    Betts, MR
    Krowka, J
    Santamaria, C
    Balsamo, K
    Gao, F
    Mulundu, G
    Luo, CW
    NGandu, N
    Sheppard, H
    Hahn, BH
    Allen, S
    Frelinger, JA
    JOURNAL OF VIROLOGY, 1997, 71 (11) : 8908 - 8911
  • [2] Safety of autologous, ex vivo expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients
    Lieberman, J
    Skolnik, PR
    Parkerson, GR
    Fabry, JA
    Landry, B
    Bethel, J
    Kagan, J
    Atkins, MB
    Gradon, J
    Stein, D
    ViraniKetter, N
    Banach, M
    Scott, M
    Meyers, J
    Lee, E
    Standiford, H
    Fong, DM
    Wang, A
    Beyer, D
    BLOOD, 1997, 90 (06) : 2196 - 2206
  • [3] Interpretation of CD4+ T-lymphocyte values in different HIV-infected populations
    Kam, KM
    Wong, KH
    Lee, SS
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (02): : 185 - 186
  • [4] HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons
    Bernard, NF
    Pederson, K
    Chung, F
    Ouellet, L
    Wainberg, MA
    Tsoukas, CM
    AIDS, 1998, 12 (16) : 2125 - 2139
  • [5] Strong Ability of Nef-Specific CD4+ Cytotoxic T Cells To Suppress Human Immunodeficiency Virus Type 1 (HIV-1) Replication in HIV-1-Infected CD4+ T Cells and Macrophages
    Zheng, Nan
    Fujiwara, Mamoru
    Ueno, Takamasa
    Oka, Shinichi
    Takiguchi, Masafumi
    JOURNAL OF VIROLOGY, 2009, 83 (15) : 7668 - 7677
  • [6] Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T Lymphocytes
    Chen, Huabiao
    Piechocka-Trocha, Alicja
    Miura, Toshiyuki
    Brockman, Mark A.
    Julg, Boris D.
    Baker, Brett M.
    Rothchild, Alissa C.
    Block, Brian L.
    Schneidewind, Arne
    Koibuchi, Tomohiko
    Pereyra, Florencia
    Allen, Todd M.
    Walker, Bruce D.
    JOURNAL OF VIROLOGY, 2009, 83 (07) : 3138 - 3149
  • [7] VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, HIV-1
    RIVIERE, Y
    CELLULAR AND MOLECULAR BIOLOGY, 1994, 40 : 45 - 48
  • [8] ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-SPECIFIC CD4+ AND CD8+ CYTOTOXIC LYMPHOCYTE-T ACTIVITIES IN HIV-INFECTED ASYMPTOMATIC PATIENTS GIVEN RECOMBINANT GP160 VACCINE
    KUNDU, SK
    KATZENSTEIN, D
    MOSES, LE
    MERIGAN, TC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) : 11204 - 11208
  • [9] Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals
    Morgan, RA
    Walker, R
    Carter, CS
    Natarajan, V
    Tavel, JA
    Bechtel, C
    Herpin, B
    Muul, L
    Zheng, ZL
    Jagannatha, S
    Bunnell, BA
    Fellowes, V
    Metcalf, JA
    Stevens, R
    Baseler, M
    Leitman, SF
    Read, EJ
    Blaese, RM
    Lane, HC
    HUMAN GENE THERAPY, 2005, 16 (09) : 1065 - 1074
  • [10] CD8+ T-LYMPHOCYTE CONTROL OF HIV REPLICATION IN CULTURED CD4+ CELLS VARIES AMONG INFECTED INDIVIDUALS
    WALKER, CM
    MOODY, DJ
    STITES, DP
    LEVY, JA
    CELLULAR IMMUNOLOGY, 1989, 119 (02) : 470 - 475